alcuni di essi sono classificati in fascia A, pertanto, il loro costo pu essere rimborsato dal Servizio Sanitario Nazionale (SSN)
Track your protein: Ensure you aren't accidentally dipping below your requirements as your appetite changes
Find a donation center near you, today
Research demonstrates that BPC-157 naturally travels to areas of tissue damage throughout the body
Peptides that degrade too quickly in saliva Saliva contains peptidases and other enzymes that, while less aggressive than gastric enzymes, still degrade susceptible peptides
25 mg/day oral Tirzepatide 15 mg/week Retatrutide 12 mg/week Liraglutide 3.0 mg/day Factor Peak trial weight loss Semaglutide -14.9% at 68 wks (STEP 1) Tirzepatide -22.5% at 72 wks (SURMOUNT-1) Retatrutide -28.7% at 68 wks (TRIUMPH-4) Liraglutide -8% at 56 wks (SCALE) Factor FDA status (June 2026) Semaglutide Approved (T2D, obesity, CVD, MASH, CKD, oral) Tirzepatide Approved (T2D, obesity) Retatrutide Investigational - Phase 3 Liraglutide Approved (Saxenda obesity, Victoza T2D) Factor CV outcomes data Semaglutide Yes - SELECT (20% MACE drop) Tirzepatide SURPASS-CVOT ongoing Retatrutide TRIUMPH-3 ongoing Liraglutide Yes - LEADER (13% MACE drop) These compounds are not interchangeable